The effect of anxiety on heart rate variability, depression, and sleep in Chronic Obstructive Pulmonary Disease

Journal of Psychosomatic Research

Volumn 74, Issue 5, 2013, Pages 407-413

  Suh, Sooyeon ^a,b   Ellis, Robert J ^c   Sollers, John J ^d   Thayer, Julian F ^e   Yang, Hae Chung ^a   Emery, Charles F ^e  

^a Korea University   (South Korea)

^b STANFORD UNIVERSITY   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

^e OHIO STATE UNIVERSITY   (United States)

Author keywords

Anxiety; Autonomic dysfunction; COPD; Heart rate variability; Stress; Trier Social Stress Task

Indexed keywords

ADULT; ANXIETY; ARTICLE; AUTONOMIC DYSFUNCTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; FEMALE; HEART RATE VARIABILITY; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; PATIENT MONITORING; PSYCHOLOGIC ASSESSMENT; QUESTIONNAIRE; SELF REPORT; SLEEP; SLEEP QUALITY;

AGED; ANXIETY DISORDERS; AUTONOMIC NERVOUS SYSTEM; COMORBIDITY; DEPRESSIVE DISORDER; FEMALE; FORCED EXPIRATORY VOLUME; HEART RATE; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; SLEEP DISORDERS; STRESS, PSYCHOLOGICAL; VITAL CAPACITY;

EID: 84876738856     PISSN: 00223999     EISSN: 18791360     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2013.02.007     Document Type: Article

References (54)

1. Mikkelsen RL, Middelboe T, Pisinger C, Stage KB Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). A review. Nord J Psychiatry 2004, 58:65-70.
2. Kim HF, Kunik ME, Molinari VA, Hillman SL, Lalani S, Orengo CA, et al. Functional impairment in COPD patients: the impact of anxiety and depression. Psychosomatics 2000, 41:465-471.
3. Hynninen KM, Breitve MH, Wiborg AB, Pallesen S, Nordhus IH Psychological characteristics of patients with chronic obstructive pulmonary disease: a review. J Psychosom Res Dec 2005, 59:429-443.
4. Ga B Anxiety and chronic obstructive pulmonary disease: prevalence, impact, and treatment. Psychosom Med 2003, 65:963-970.
5. Willgoss TG, Yohannes AM. Anxiety disorders in patients with chronic obstructive pulmonary disease: a systematic review. Respir Care in press. http://dx.doi.org/10.4187/respcare.01862.
6. Fuhs M. Correlates of dyspnea in individuals with chronic obstructive pulmonary disorders 1980, The Catholic University of America, Washington DC.
7. Burns BH, Howell JB Disproportionately severe breathlessness in chronic bronchitis. Q J Med Jul 1969, 38:277-294.
8. Unutzer J, Patrick DL, Simon G, Grembowski D, Walker E, Rutter C, et al. Depressive symptoms and the cost of health services in HMO patients aged 65years and older. A 4-year prospective study. JAMA May 28 1997, 277:1618-1623.
9. Borson S, McDonald GJ, Gayle T, Deffebach M, Lakshminarayan S, VanTuinen C Improvement in mood, physical symptoms, and function with nortriptyline for depression in patients with chronic obstructive pulmonary disease. Psychosomatics Spring 1992, 33:190-201.
10. Beck J.G., Scott S.K., Teague R.B. Correlates of daily impairment in COPD. Rehabil Psychol 1988, 33:77-84.
11. McSweeny A.J. Quality of life in relation to COPD 1988, Marcel Dekker, Inc., New York. A.J. McSweeny, I. Grant (Eds.).
12. Bedard ME, Marquis K, Poirier P, Provencher S Reduced heart rate variability in patients with chronic obstructive pulmonary disease independent of anticholinergic or beta-agonist medications. COPD Dec 2010, 7:391-397.
13. Camillo CA, Laburu Vde M, Goncalves NS, Cavalheri V, Tomasi FP, Hernandes NA, et al. Improvement of heart rate variability after exercise training and its predictors in COPD. Respir Med Jul 2011, 105:1054-1062.
14. Carvalho TD, Pastre CM, de Godoy MF, Fereira C, Pitta FO, de Abreu LC, et al. Fractal correlation property of heart rate variability in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2011, 6:23-28. [Research Support, Non-U.S. Gov't].
15. Dias de Carvalho T, Marcelo Pastre C, Claudino Rossi R, de Abreu LC, Valenti VE, Marques Vanderlei LC Geometric index of heart rate variability in chronic obstructive pulmonary disease. Rev Port Pneumol 2011, 17:260-265.
16. Stein PKNP, Rottman JN, Howard D, Ward SM, Kleiger RE, Senior RM Heart rate variability reflects severity of COPD in PiZ alpha1-antitrypsin deficiency. Chest 1988, 113:327-333.
17. Volterrani M, Scalvini S, Mazzuero G, Lanfranchi P, Colombo R, Clark AL, et al. Decreased heart rate variability in patients with chronic obstructive pulmonary disease. Chest Nov 1994, 106:1432-1437. [Comparative Study].
18. Bartels MN, Jelic S, Ngai P, Basner RC, DeMeersman RE High-frequency modulation of heart rate variability during exercise in patients with COPD. Chest Sep 2003, 124:863-869.
19. Friedman BH, Thayer JF Anxiety and autonomic flexibility: a cardiovascular approach. Biol Psychol Nov 1998, 49:303-323.
20. Friedman BH, Thayer JF, Borkovec TD, Tyrrell RA, Johnson BH, Columbo R Autonomic characteristics of nonclinical panic and blood phobia. Biol Psychiatry Sep 1 1993, 34:298-310. [Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.].
21. Klein E, Cnaani E, Harel T, Braun S, Ben-Haim SA Altered heart rate variability in panic disorder patients. Biol Psychiatry Jan 1 1995, 37:18-24. [c].
22. Middleton HC, Ashby M, Robbins TW Reduced plasma noradrenaline and abnormal heart rate variability in resting panic disorder patients. Biol Psychiatry Dec 15 1994, 36:847-849.
23. Ost LG, Sterner U, Lindahl IL Physiological responses in blood phobics. Behav Res Ther 1984, 22:109-117.
24. Rechlin T, Weis M, Spitzer A, Kaschka WP Are affective disorders associated with alterations of heart rate variability?. J Affect Disord Dec 1994, 32:271-275.
25. Thayer JF, Friedman BH Assessment of anxiety using heart rate nonlinear dynamics. Chaos in biology and medicine: proceedings of the international society for optical engineering 1993, 42-48. W. Ditto (Ed.).
26. Thayer JF, Lane RD A model of neurovisceral integration in emotion regulation and dysregulation. J Affect Disord Dec 2000, 61:201-216.
27. Yeragani VK, Balon R, Pohl R, Ramesh C, Glitz D, Weinberg P, et al. Decreased R-R variance in panic disorder patients. Acta Psychiatr Scand Jun 1990, 81:554-559. [Research Support, U.S. Gov't, P.H.S.].
28. Yeragani VK, Pohl R, Berger R, Balon R, Ramesh C, Glitz D, et al. Decreased heart rate variability in panic disorder patients: a study of power-spectral analysis of heart rate. Psychiatry Res Jan 1993, 46:89-103.
29. Yeragani VK, Pohl R, Srinivasan K, Balon R, Ramesh C, Berchou R Effects of isoproterenol infusions on heart rate variability in patients with panic disorder. Psychiatry Res Apr 28 1995, 56:289-293.
30. Yeragani V.K., Pohl R., Balon R., Ramesh C., Glitz D., Weinberg P., Merlos B. Effects of imipramine treatment on heart rate variability measures. Neuropsychobiology 1992, 26:27-32.
31. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med Sep 15 2007, 176:532-555. [Review].
32. Spielberger CD Assessment of state and trait anxiety: conceptual and methodological issues. Southern Psychol 1985, 2:6-16.
33. Kirschbaum C, Schommer N, Federenko I, Gaab J, Neumann O, Oellers M, et al. Short-term estradiol treatment enhances pituitary-adrenal axis and sympathetic responses to psychosocial stress in healthy young men. J Clin Endocrinol Metabol Oct 1996, 81:3639-3643.
34. Vanderlei LC, Silva RA, Pastre CM, Azevedo FM, Godoy MF Comparison of the Polar S810i monitor and the ECG for the analysis of heart rate variability in the time and frequency domains. Braz J Med Biol Res Oct 2008, 41:854-859. [Comparative Study Research Support, Non-U.S. Gov't].
35. Weippert M, Kumar M, Kreuzfeld S, Arndt D, Rieger A, Stoll R Comparison of three mobile devices for measuring R-R intervals and heart rate variability: Polar S810i, Suunto t6 and an ambulatory ECG system. Eur J Appl Physiol Jul 2010, 109:779-786.
36. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation Mar 1 1996, 93:1043-1065.
37. Vanderlei LC, Pastre CM, Hoshi RA, Carvalho TD, Godoy MF Basic notions of heart rate variability and its clinical applicability. Rev Bras Cir Cardiovasc 2009, 24:205-217.
38. Berntson GG, Bigger JT, Eckberg DL, Grossman P, Kaufmann PG, Malik M, et al. Heart rate variability: origins, methods, and interpretive caveats. Psychophysiology Nov 1997, 34:623-648.
39. Thayer JF, Sollers JJ, Ruiz-Padial E, Vila J Estimating respiratory frequency from autoregressive spectral analysis of heart period. IEEE Eng Med Biol Mag 2002, 21:41-45.
40. Klink M, Quan SF Prevalence of reported sleep disturbances in a general adult population and their relationship to obstructive airways diseases. Chest Apr 1987, 91:540-546.
41. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res May 1989, 28:193-213. [Research Support, U.S. Gov't, P.H.S.].
42. Radloff L.S. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977, 1:385-401.
43. Miller MR, Crapo R, Hankinson J, Brusasco V, Burgos F, Casaburi R, et al. General considerations for lung function testing. Eur Respir J Jul 2005, 26:153-161.
44. Macintyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CP, Brusasco V, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J Oct 2005, 26:720-735.
45. Goldberger JJ, Challapalli S, Tung R, Parker MA, Kadish AH Relationship of heart rate variability to parasympathetic effect. Circulation Apr 17 2001, 103:1977-1983.
46. Umetani K, Singer DH, McCraty R, Atkinson M Twenty-four hour time domain heart rate variability and heart rate: relations to age and gender over nine decades. J Am Coll Cardiol Mar 1 1998, 31:593-601.
47. Simes RJ An improved Bonferroni procedure for multiple tests of significance. Biometrika 1986, 73:751-754.
48. Buda AJ, Pinsky MR, Ingels NB, Daughters GT, Stinson EB, Alderman EL Effect of intrathoracic pressure on left ventricular performance. N Engl J Med Aug 30 1979, 301:453-459. [Research Support, U.S. Gov't, P.H.S.].
49. Hoehn-Saric R, McLeod DR The peripheral sympathetic nervous system. Its role in normal and pathologic anxiety. Psychiatr Clin North Am Jun 1988, 11:375-386. [Review].
50. Marin JM, Carrizo SJ, Gascon M, Sanchez A, Gallego B, Celli BR Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease. Am J Respir Crit Care Med May 2001, 163:1395-1399. [Validation Studies].
51. Stewart AG, Waterhouse JC, Howard P Cardiovascular autonomic nerve function in patients with hypoxaemic chronic obstructive pulmonary disease. Eur Respir J Nov 1991, 4:1207-1214.
52. Pagani M, Lucini D, Pizzinelli P, Sergi M, Bosisio E, Mela GS, et al. Effects of aging and of chronic obstructive pulmonary disease on RR interval variability. J Auton Nerv Syst Jul 5 1996, 59:125-132.
53. Dagnone AJ, Parlow JL Effects of inhaled albuterol and ipratropium bromide on autonomic control of the cardiovascular system. Chest Jun 1997, 111:1514-1518.
54. Rossinen J, Partanen J, Stenius-Aarniala B, Nieminen MS Salbutamol inhalation has no effect on myocardial ischaemia, arrhythmias and heart-rate variability in patients with coronary artery disease plus asthma or chronic obstructive pulmonary disease. J Intern Med May 1998, 243:361-366.